SpaceX Stock Has Pulled Back 32%. Time to Buy?

SpaceX reported 2025 revenue of $18.7 billion, up 33% year over year, but still posted a $4.9 billion net loss. Starlink generated $11.4 billion of revenue and about $4.4 billion of operating profit, while xAI added $3.2 billion of revenue but remained loss-making. Despite a 32% post-IPO pullback, the stock still trades at more than 100 times sales, and the article argues the valuation remains stretched.

Analysis

The first-order read is “expensive growth,” but the more important signal is capital intensity. When the market prices a still-loss-making platform at triple-digit sales, it is implicitly underwriting a step-change in free cash flow that requires both launch execution and monetization discipline in parallel; that is a much higher bar than simply sustaining subscriber growth. The setup is fragile because the valuation leaves little room for the usual aerospace failure modes: schedule slips, launch cost overruns, or a slower-than-expected payoff from adjacent AI assets.

The cleaner second-order winner is not the company itself but the ecosystem around it. If capital remains abundant for vertically integrated space/AI platforms, private-market investors will keep marking up “picks-and-shovels” suppliers, ground infrastructure, and launch-adjacent software with less operating risk and faster cash conversion. Conversely, public comps in high-multiple growth tech can trade more defensively on any sign that investors are rotating from narrative-driven names toward profitability and balance-sheet quality.

The contrarian issue is that sentiment can dominate fundamentals for much longer than valuation purists expect, especially with a founder-led brand and a retail-heavy shareholder base. Near term, that means the stock can squeeze higher on milestone headlines even if the underlying economics are not yet compelling. But over a 3-12 month horizon, the burden of proof shifts to proving that incremental growth is not being bought with disproportionate capex and losses elsewhere in the stack.

For listed peers and related sentiment, the main risk is not direct operating exposure but factor contagion: a disappointment here can compress multiples across private-tech/space/AI beta. That creates a tactical opportunity to fade overstretched duration-equity exposures if the stock stabilizes at a still-lofty level rather than collapsing outright; the better trade is often relative-value, not naked directionality.

Key Decisions for Investors

• Avoid initiating a long outright position in the name for the next 1-3 months; valuation leaves asymmetric downside if the next disclosure emphasizes capex, losses, or slower monetization.
• If accessible through derivatives or proxies, consider a 3-6 month bearish structure such as a put spread on the stock or a short call spread against a strong post-news rally; define risk tightly because sentiment can remain bid longer than fundamentals justify.
• Run a relative-value pair: long profitable, cash-generative aerospace/defense beneficiaries versus short high-multiple private-tech/AI beta over 3-6 months; the thesis is multiple compression, not company-specific collapse.
• Use any continued strength as a chance to reduce exposure to other momentum names with similar narrative/retail ownership profiles over the next 2-8 weeks, since this could be a sentiment barometer for the broader growth complex.
• If the stock drops another 15-20% without a clear deterioration in operating metrics, reassess for a tactical trade only; the better risk/reward would require evidence of margin inflection or capex moderation, not just a lower headline price.